Heart Disease Clinical Trials in Massachusetts

211 recruiting studies across 1 city

Browse by City

All Trials in Massachusetts

Phase

Trial	Phase	Sponsor	Dist.
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function	Phase 3	AstraZeneca	<1 mi
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)	N/A	Medtronic Cardiac Ablation Solutions	<1 mi
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System	N/A	Boston Scientific Corporation	<1 mi
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions	N/A	Boston Scientific Corporation	<1 mi
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	Phase 3	Johns Hopkins University	<1 mi
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery	Phase 3	Yale University	<1 mi
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF	Phase 3	Tenax Therapeutics, Inc.	<1 mi
SELUTION 4 De Novo Small Vessel IDE Trial	N/A	M.A. Med Alliance S.A.	<1 mi
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Phase 4	Dennis M. McNamara, MD, MS	<1 mi
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement	N/A	University of British Columbia	<1 mi
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study	N/A	Ancora Heart, Inc.	<1 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment	—	Children's Oncology Group	<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	<1 mi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin	Phase 3	AstraZeneca	<1 mi
Pediatric Adhesion and New Dermal Approach Study	N/A	iRhythm Technologies, Inc.	<1 mi
Autus Valve Pivotal Study	N/A	Autus Valve Technologies, Inc.	<1 mi
ASCEND CSP IDE Study	N/A	Abbott Medical Devices	<1 mi
PV Loop & Coarctation Study	—	University of Minnesota	<1 mi
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)	Phase 1	Solid Biosciences Inc.	<1 mi
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy	Phase 3	Lexicon Pharmaceuticals	<1 mi
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial	N/A	Edwards Lifesciences	<1 mi
Ultrasound Therapy In Cardiac Amyloidosis	Phase 4	Brigham and Women's Hospital	<1 mi
The HALT Biomarker Study	Phase 1	Massachusetts General Hospital	<1 mi
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure	N/A	McMaster University	<1 mi
Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study	Early 1	Boston Children's Hospital	<1 mi
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC	Phase 1	Tenaya Therapeutics	<1 mi
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment	N/A	XSpline S.p.A.	<1 mi
Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst	—	Boston Medical Center	<1 mi
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health	N/A	Massachusetts General Hospital	<1 mi
Real-world Patient Reported Outcomes Among Patients Treated With Camzyos	—	Bristol-Myers Squibb	<1 mi
Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)	N/A	Gradient Denervation Technologies	<1 mi
The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease	N/A	Massachusetts General Hospital	<1 mi
Reducing Risk for Infective Endocarditis	N/A	Wake Forest University Health Sciences	<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease	—	Children's Hospital Medical Center, Cincinnati	<1 mi
A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System	N/A	Vectorious Medical Technologies Ltd.	<1 mi
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention	N/A	Brigham and Women's Hospital	<1 mi
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry	—	Universitätsklinikum Hamburg-Eppendorf	<1 mi
CEReBral AutorEgulation in Non-cardiac SuRgery and Relationship to Postoperative DeliriUm State	—	Beth Israel Deaconess Medical Center	<1 mi
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions	Phase 4	Yale University	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk	Phase 4	Brigham and Women's Hospital	<1 mi
MASA Valve Early Feasibility Study	N/A	PECA Labs	<1 mi
Quality of Pediatric Resuscitation in a Multicenter Collaborative	—	Children's Hospital of Philadelphia	<1 mi
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)	N/A	Fundación EPIC	<1 mi
US Benchmarking Clinical Study	—	eMyosound SAS	<1 mi
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System	N/A	HighLife SAS	<1 mi
Promoting Well-being and Health in Heart Failure	N/A	Massachusetts General Hospital	<1 mi
Molecular Imaging of Primary Amyloid Cardiomyopathy	N/A	Brigham and Women's Hospital	<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	<1 mi
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure	—	Tufts Medical Center	<1 mi
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure	N/A	Abbott Medical Devices	<1 mi
J-Valve Transfemoral Pivotal Study	N/A	JC Medical, Inc., an affiliate of Edwards Lifesciences LLC	<1 mi
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III	N/A	Endotronix, Inc.	<1 mi
Clinical Course Of Disease In Participants With FA-CM	—	Lexeo Therapeutics	<1 mi
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO Study	N/A	Recross Cardio, Inc.	<1 mi
The ENCIRCLE Trial	N/A	Edwards Lifesciences	<1 mi
The Relationship Between Brain MRI Phenotypes, Genes and Cognitive Outcome in CHD Adults	N/A	Boston Children's Hospital	<1 mi
Warfarin Patient Self-management Implementation in the US Healthcare System	N/A	University of Utah	<1 mi
Supplemental Oxygen in Pulmonary Embolism (SO-PE)	Early 1	Massachusetts General Hospital	<1 mi
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction	N/A	Edwards Lifesciences	<1 mi
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR	N/A	Edwards Lifesciences	<1 mi
Improving Coronary Vascular Health in Women	Phase 2	Massachusetts General Hospital	<1 mi
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis	Phase 2	Zomagen Biosciences Ltd.	<1 mi
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy	Phase 3	Alnylam Pharmaceuticals	<1 mi
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study	N/A	Starlight Cardiovascular Inc	<1 mi
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass	Phase 3	Octapharma	<1 mi
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy	N/A	Rush University Medical Center	<1 mi
Care Transitions App for Patients With Multiple Chronic Conditions	N/A	Brigham and Women's Hospital	<1 mi
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)	Phase 4	Massachusetts General Hospital	<1 mi
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry	—	SCAD Alliance	<1 mi
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy	Phase 2	Imbria Pharmaceuticals, Inc.	<1 mi
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants	N/A	Nationwide Children's Hospital	<1 mi
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)	Phase 3	Intellia Therapeutics	<1 mi
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI	—	Beth Israel Deaconess Medical Center	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)	—	Bristol-Myers Squibb	<1 mi
Positive Emotions Following Acute Cardiac Events	N/A	Massachusetts General Hospital	<1 mi
Minima Stent System Post- Approval Study (PAS)	—	Renata Medical	<1 mi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure	N/A	BrioHealth Solutions, Inc.	<1 mi
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction	Phase 3	Bayer	<1 mi
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease	Phase 2	Rocket Pharmaceuticals Inc.	<1 mi
PARTNER 3 Trial - Aortic Valve-in-Valve	N/A	Edwards Lifesciences	<1 mi
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study	N/A	W.L.Gore & Associates	<1 mi
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy	N/A	University of Rochester	<1 mi
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)	—	Brigham and Women's Hospital	<1 mi
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study	N/A	Brigham and Women's Hospital	<1 mi
Optimal Ventilation for Cardiac Arrest	N/A	Children's Hospital of Philadelphia	<1 mi
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM	Phase 1/2	Tenaya Therapeutics	<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	<1 mi
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients	Phase 4	University of Rochester	<1 mi
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF	N/A	Massachusetts General Hospital	<1 mi
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)	N/A	P+F Products + Features USA Inc.	<1 mi
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)	Phase 3	Cardiol Therapeutics Inc.	<1 mi
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE	—	Medtronic Cardiovascular	<1 mi
Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)	Phase 2/3	Thryv Therapeutics, Inc.	<1 mi
Imaging Histone Deacetylase in the Heart	N/A	Massachusetts General Hospital	<1 mi
Evaluation of Pro-Inflammatory Leukocyte Activity in Patients Undergoing Cardiac Surgery	—	Boston Children's Hospital	<1 mi
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation	N/A	Boston Scientific Corporation	<1 mi
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery	—	Brigham and Women's Hospital	<1 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women	Phase 3	Weill Medical College of Cornell University	<1 mi
A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure	N/A	Tufts Medical Center	<1 mi
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)	Phase 2	Tectonic Therapeutic	<1 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR	N/A	Cardiac Dimensions, Inc.	<1 mi
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block	—	The Hospital for Sick Children	<1 mi
EluPro Antibiotic-Eluting BioEnvelope Registry	—	Elutia Inc.	<1 mi
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension	Phase 4	Brigham and Women's Hospital	<1 mi
Left vs Left Randomized Clinical Trial	N/A	Baylor College of Medicine	<1 mi
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.	Phase 4	Pfizer	<1 mi
Product Surveillance Registry	—	Medtronic	<1 mi
Simulation Trial of Telemedical Support for Paramedics	N/A	Boston Medical Center	<1 mi
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products	—	Medtronic	<1 mi
Allogeneic Valve Transplantation	N/A	Boston Children's Hospital	<1 mi
Exercise Training in Transthyretin Cardiac Amyloidosis	N/A	Brigham and Women's Hospital	<1 mi
Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study	N/A	Massachusetts General Hospital	<1 mi
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis	Phase 2	Novartis Pharmaceuticals	<1 mi
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis	—	Boston Children's Hospital	<1 mi
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study	Phase 2/3	Kardigan, Inc.	<1 mi
Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis	Phase 3	Brigham and Women's Hospital	<1 mi
Cardiogenic Shock Working Group Registry	—	Tufts Medical Center	<1 mi
Effects of Age, Sex and Isometric Exercise on Ventricular-Vascular Interactions During Cardiac Unloading	N/A	Tracy Baynard	<1 mi
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions	N/A	Concept Medical Inc.	<1 mi
The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease	—	Brigham and Women's Hospital	<1 mi
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery	—	Brigham and Women's Hospital	<1 mi
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation	—	Heart Rhythm Clinical and Research Solutions, LLC	<1 mi
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease	—	Boston Children's Hospital	<1 mi
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty	N/A	VA Office of Research and Development	<1 mi
Lumason® Infusion vs. Bolus Administrations	Phase 3	Bracco Diagnostics, Inc	<1 mi
Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure	—	Massachusetts General Hospital	<1 mi
Cardiac Sarcoidosis Randomized Trial	Phase 3	Ottawa Heart Institute Research Corporation	<1 mi
HCMR Re-Imaging Study	—	Christopher Kramer	<1 mi
CTSN Embolic Protection Trial	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG	Phase 3	Icahn School of Medicine at Mount Sinai	<1 mi
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Phase 3	Mezzion Pharma Co. Ltd	<1 mi
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)	N/A	Annetine Gelijns	<1 mi
Abatacept in Immune Checkpoint Inhibitor Myocarditis	Phase 3	Massachusetts General Hospital	<1 mi
FORWARD CAD IDE Study	N/A	Shockwave Medical, Inc.	<1 mi
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm	N/A	Kardion Inc	<1 mi
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)	N/A	Medtronic Cardiac Ablation Solutions	<1 mi
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves	N/A	Edwards Lifesciences	<1 mi
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis	—	Columbia University	<1 mi
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.	—	Heart Rhythm Clinical and Research Solutions, LLC	<1 mi
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets	—	Northwestern University	<1 mi
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients	Phase 3	Colorado Prevention Center	<1 mi
Hydrogen's Feasibility and Safety as a Therapy in ECPR	Phase 1	Boston Children's Hospital	<1 mi
The STOP-MED CTRCD Trial	Phase 4	University Health Network, Toronto	<1 mi
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)	N/A	Varian, a Siemens Healthineers Company	<1 mi
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)	Phase 2/3	Merck Sharp & Dohme LLC	<1 mi
A Clinical Trial to Study the Feasibility and Acceptability of an App to Support Pediatric Resuscitation	N/A	Beth Israel Deaconess Medical Center	<1 mi
PRIMARY Ancillary Substudy	N/A	Annetine Gelijns	<1 mi
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health	N/A	Massachusetts General Hospital	<1 mi
Medtronic Terminate AF Study	N/A	Medtronic Cardiac Surgery	<1 mi
Purinergic Signaling and the Postmenopausal Heart	—	Beth Israel Deaconess Medical Center	<1 mi
Left Bundle Branch Area Mapping for Conduction System Pacing	—	Steward St. Elizabeth's Medical Center of Boston, Inc.	<1 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction	Phase 3	Cytokinetics	<1 mi
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).	N/A	Mayra Guerrero	<1 mi
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)	Phase 3	Anthos Therapeutics, Inc.	<1 mi
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures	—	Boston Children's Hospital	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
TECTONIC CAD IVL IDE Study	N/A	Abbott Medical Devices	<1 mi
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine	Phase 4	Massachusetts General Hospital	<1 mi
Pulmonary Artery Catheter in Cardiogenic Shock Trial	N/A	Tufts Medical Center	<1 mi
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment	Phase 2	BioMarin Pharmaceutical	<1 mi
Assessment of CCM in HF With Higher Ejection Fraction	N/A	Impulse Dynamics	<1 mi
Study of JK07 in Patients With Chronic Heart Failure	Phase 2	Salubris Biotherapeutics Inc	<1 mi
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™	N/A	JenaValve Technology, Inc.	<1 mi
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction	—	Northwestern University	<1 mi
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)	N/A	Western Sydney Local Health District	<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities	Phase 3	Weill Medical College of Cornell University	<1 mi
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF	Phase 2	Cytokinetics	<1 mi
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)	—	Tenaya Therapeutics	<1 mi
Physio-Anatomy Clinical Data Collection Study	—	Gentuity, LLC	<1 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events	Phase 3	Amgen	<1 mi
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II	N/A	Shockwave Medical, Inc.	<1 mi
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)	N/A	Biosense Webster, Inc.	<1 mi
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)	N/A	University of Michigan	<1 mi
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.	N/A	Medtronic Cardiovascular	<1 mi
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System	N/A	Aria CV, Inc	<1 mi
PKP2-ACM Natural History Study	—	Rocket Pharmaceuticals Inc.	<1 mi
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study	—	Brigham and Women's Hospital	<1 mi
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)	N/A	Boston Medical Center	<1 mi
Home Hospital for Suddenly Ill Adults	N/A	Brigham and Women's Hospital	<1 mi
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF	N/A	Beth Israel Deaconess Medical Center	<1 mi
Foundational Programs to Combat Clinician Stress	N/A	Lancaster General Hospital	<1 mi
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest	N/A	Massachusetts General Hospital	<1 mi
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer	—	National Cancer Institute (NCI)	<1 mi
Positron Emission Tomography (PET) Imaging of Thrombosis	Phase 1	Massachusetts General Hospital	<1 mi
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome	Phase 3	Albireo, an Ipsen Company	<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	<1 mi
Diffusion MRI in Heart Failure	Early 1	Massachusetts General Hospital	1 mi
The Mycophenolate Pregnancy Registry	—	Genentech, Inc.	3 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity	Phase 3	SWOG Cancer Research Network	8 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	8 mi
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives	—	Sanguine Biosciences	9 mi
Personalized Responses to Dietary Composition Trial 3	N/A	Zoe Global Limited	10 mi
The Fourth Left Atrial Appendage Occlusion Study	N/A	Hamilton Health Sciences Corporation	12 mi
The CONFORM Pivotal Trial	N/A	Conformal Medical, Inc	12 mi
RESPONDER-HF Trial	N/A	Corvia Medical	12 mi
Assessment of Left Ventricular Filling Pressure by Applying Artificial Intelligence Algorithms to Left Atrial Speckle-tracking Echocardiography	—	Istituto Auxologico Italiano	21 mi
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation	Phase 3	Novo Nordisk A/S	29 mi
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women	N/A	Weill Medical College of Cornell University	39 mi
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices	N/A	Andres Schanzer	39 mi
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)	Phase 3	Boehringer Ingelheim	41 mi
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS	Phase 3	DalCor Pharmaceuticals	41 mi
SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation	N/A	The Miriam Hospital	41 mi
Prevail Global Study	N/A	Medtronic Vascular	41 mi
Mind Your Heart-II	N/A	The Miriam Hospital	41 mi
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)	Phase 2	Merck Sharp & Dohme LLC	41 mi
Supporting Health in Veterans With Heart Failure	N/A	Florida State University	41 mi
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure	N/A	Boston Scientific Corporation	46 mi
PULSED AF Post-Approval Study	—	Medtronic Cardiac Ablation Solutions	46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.